These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23152437)

  • 41. [Effects of small interfering RNA targeting basic fibroblast growth factor on proliferation and apoptosis of glioma cell line U251].
    Wang SJ; Wang JH; Zhang YW; Xu XN; Liu HS
    Ai Zheng; 2008 Sep; 27(9):905-9. PubMed ID: 18799025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
    Saitoh Y; Martínez Bruyn VJ; Uota S; Hasegawa A; Yamamoto N; Imoto I; Inazawa J; Yamaoka S
    Lung Cancer; 2010 Dec; 70(3):263-70. PubMed ID: 20338663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small interfering RNA transfection against serum response factor mediates growth inhibition of benign prostatic hyperplasia fibroblasts.
    Nolte A; Aufderklamm S; Scheu K; Walker T; König O; Böttcher M; Niederlaender J; Schwentner C; Schlensak C; Stenzl A; Wendel HP
    Nucleic Acid Ther; 2013 Feb; 23(1):62-70. PubMed ID: 23308381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.
    Kumar K; Maiti B; Kondaiah P; Bhattacharya S
    Mol Pharm; 2015 Feb; 12(2):351-61. PubMed ID: 25438085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced Anti-Tumor Efficacy of Lipid-Modified Platinum Derivatives in Combination with Survivin Silencing siRNA in Resistant Non-Small Cell Lung Cancer.
    Mattheolabakis G; Ling D; Ahmad G; Amiji M
    Pharm Res; 2016 Dec; 33(12):2943-2953. PubMed ID: 27528390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
    McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M
    Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.
    Tian H; Liu S; Zhang J; Zhang S; Cheng L; Li C; Zhang X; Dail L; Fan P; Dai L; Yan N; Wang R; Wei Y; Deng H
    J Biomed Nanotechnol; 2012 Aug; 8(4):633-41. PubMed ID: 22852473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-small cell lung carcinoma therapy using mTOR-siRNA.
    Matsubara H; Sakakibara K; Kunimitsu T; Matsuoka H; Kato K; Oyachi N; Dobashi Y; Matsumoto M
    Int J Clin Exp Pathol; 2012; 5(2):119-25. PubMed ID: 22400071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Survivin gene silencing inhibits the proliferation of human gastric cancer MGC-803 cells and enhances their sensitivity to celecoxib].
    Fang L; Wu HB; Chen XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1944-8. PubMed ID: 22126788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficient inhibition of non-small-cell lung cancer xenograft by systemic delivery of plasmid-encoding short-hairpin RNA targeting VEGF.
    Yang Y; Bai Y; Xie G; Zhang N; Ma YP; Chen LJ; Jiang Y; Zhao X; Wei YQ; Deng HX
    Cancer Biother Radiopharm; 2010 Feb; 25(1):65-73. PubMed ID: 20187798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TRIM28 knockdown increases sensitivity to etoposide by upregulating E2F1 in non-small cell lung cancer.
    Liu L; Xiao L; Liang X; Chen L; Cheng L; Zhang L; Wu X; Xu Q; Ma C
    Oncol Rep; 2017 Jun; 37(6):3597-3605. PubMed ID: 28498400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic delivery of sticky siRNAs targeting the cell cycle for lung tumor metastasis inhibition.
    Bonnet ME; Gossart JB; Benoit E; Messmer M; Zounib O; Moreau V; Behr JP; Lenne-Samuel N; Kedinger V; Meulle A; Erbacher P; Bolcato-Bellemin AL
    J Control Release; 2013 Sep; 170(2):183-90. PubMed ID: 23727288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumor activity of a novel survivin siRNA.
    Li Y; Li Y; Lee RJ; Wang X; Du L; Zhao L; Liu Y; Teng L
    Pak J Pharm Sci; 2015 Sep; 28(5 Suppl):1887-90. PubMed ID: 26525031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
    Ji ZJ; Wang JL; Chen L
    Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
    Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Suppression of survivin gene in leukemia cells by small interfering RNA].
    Wang TY; Feng SQ; Zhang ZX; Shi XD; Liu R; Liu ZQ
    Zhonghua Er Ke Za Zhi; 2010 Nov; 48(11):843-7. PubMed ID: 21215029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dysregulation of FURIN by prostaglandin-endoperoxide synthase 2 in lung epithelial NCI-H292 cells.
    Brant KA; Leikauf GD
    Mol Carcinog; 2014 Mar; 53(3):192-200. PubMed ID: 23065687
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5'-triphosphate-siRNA against survivin gene induces interferon production and inhibits proliferation of lung cancer cells in vitro.
    Wang K; Chen X; Yan F; Xing Y; Yang X; Tu J; Chen Z
    J Immunother; 2013 Jun; 36(5):294-304. PubMed ID: 23719240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of survivin expression by small interfering RNA suppresses proliferation of two human cancer cell lines.
    Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
    Chin Med Sci J; 2006 Jun; 21(2):115-9. PubMed ID: 16845800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Biological behaviors and chemosensitivity of NSCLC A549 cells after IGF-IR gene silencing by targeting RNAi in vitro].
    Kong MJ; Dong AQ; Wu W; Ma ZY; Cheng HF; Qian JF; Fan JQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 37(4):373-80. PubMed ID: 18705010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.